Akso Health Group (AHG)
1.21
+0.04
(+3.42%)
USD |
NASDAQ |
Oct 07, 16:00
Akso Health Group Enterprise Value : 1.042B for Oct. 7, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 07, 2026 | 1.042B |
| October 06, 2026 | 1.008B |
| October 05, 2026 | 999.36M |
| October 02, 2026 | 990.82M |
| October 01, 2026 | 879.79M |
| September 30, 2026 | 777.30M |
| September 29, 2026 | 598.81M |
| September 28, 2026 | 632.97M |
| September 25, 2026 | 649.20M |
| September 24, 2026 | 657.74M |
| September 23, 2026 | 666.19M |
| September 22, 2026 | 640.74M |
| September 21, 2026 | 657.74M |
| September 18, 2026 | 650.31M |
| September 17, 2026 | 649.20M |
| September 16, 2026 | 645.01M |
| September 15, 2026 | 657.74M |
| September 14, 2026 | 693.44M |
| September 11, 2026 | 725.38M |
| September 10, 2026 | 632.29M |
| September 09, 2026 | 691.99M |
| September 08, 2026 | 706.25M |
| September 04, 2026 | 732.89M |
| September 03, 2026 | 754.93M |
| September 02, 2026 | 734.60M |
| Date | Value |
|---|---|
| September 01, 2026 | 777.30M |
| August 31, 2026 | 777.30M |
| August 28, 2026 | 740.41M |
| August 27, 2026 | 845.63M |
| August 26, 2026 | 854.17M |
| August 25, 2026 | 849.22M |
| August 24, 2026 | 814.07M |
| August 21, 2026 | 802.67M |
| August 20, 2026 | 879.79M |
| August 19, 2026 | 834.27M |
| August 18, 2026 | 901.14M |
| August 17, 2026 | 1.042B |
| August 14, 2026 | 1.093B |
| August 13, 2026 | 1.119B |
| August 12, 2026 | 1.264B |
| August 11, 2026 | 1.196B |
| August 10, 2026 | 1.162B |
| August 07, 2026 | 1.162B |
| August 06, 2026 | 1.136B |
| August 05, 2026 | 1.256B |
| August 04, 2026 | 1.227B |
| August 03, 2026 | 1.145B |
| July 31, 2026 | 1.350B |
| July 30, 2026 | 1.367B |
| July 29, 2026 | 1.256B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Interpace Biosciences, Inc. | 31.53M |
| Virax Biolabs Group Ltd. | -- |
| Sinovac Biotech Ltd. | -210.46M |
| China Pharma Holdings, Inc. | 38.04M |
| CASI Pharmaceuticals, Inc. | -- |
Enterprise Value Related Metrics
| Earnings Yield | -1.87% |
| Normalized Earnings Yield | -0.7355 |